Hilde Ytre-Hauge Smeland (Rolf K Reed)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Sentinel Lymph Node

Top Venues

Scientific reports

The journal of pathology. Clinical research

This page only lists publications with an associated author ORCID identifier.

Publications

Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, Gro Gausdal, David Micklem, Petri Kursula, Cara Ellen Wogsland, Hilde Ytre-Hauge Smeland
In vivo turnover and biodistribution of soluble AXL: implications for biomarker development. Scientific reports 14 (1) (2024)
Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, Gro Gausdal, David Micklem, Petri Kursula, Cara Ellen Wogsland, Hilde Ytre-Hauge Smeland
In vivo turnover and biodistribution of soluble AXL: implications for biomarker development. Scientific reports 14 (1) (2024)
Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, Gro Gausdal, David Micklem, Petri Kursula, Cara Ellen Wogsland, Hilde Ytre-Hauge Smeland
In vivo turnover and biodistribution of soluble AXL: implications for biomarker development. Scientific reports 14 (1) (2024)
Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, Gro Gausdal, David Micklem, Petri Kursula, Cara Ellen Wogsland, Hilde Ytre-Hauge Smeland
In vivo turnover and biodistribution of soluble AXL: implications for biomarker development. Scientific reports 14 (1) (2024)
Hilde Ytre-Hauge Smeland, Ning Lu, Tine V Karlsen, Gerd Salvesen, Rolf K Reed, Linda Stuhr
Stromal integrin α11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors. BMC cancer 19 (1) (2019)
Hilde Ytre-Hauge Smeland, Cecilie Askeland, Elisabeth Wik, Gøril Knutsvik, Anders Molven, Reidunn J Edelmann, Rolf K Reed, David J Warren, Donald Gullberg, Linda Stuhr, Lars A Akslen
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes. The journal of pathology. Clinical research 6 (1) (2019)